2.18
price down icon4.39%   -0.10
after-market Dopo l'orario di chiusura: 2.18
loading

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Income/Loss From Continuing Operations Before Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Net Income/Loss
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.43
price up icon 0.31%
$97.31
price down icon 0.33%
$31.50
price down icon 0.66%
$91.46
price down icon 0.15%
biotechnology ONC
$307.02
price up icon 0.32%
$166.55
price down icon 16.08%
Capitalizzazione:     |  Volume (24 ore):